Lung Transplant Clinical Trial
Official title:
Clinical Trial of Ex Vivo Lung Perfusion (EVLP) for the Reconditioning of Marginal Donor Lungs for Transplantation.
The overall objective of this study is to evaluate the clinical effectiveness of the novel technique of donor EVLP in increasing lung transplant activity by allowing previously unusable donor lungs to be safely used in clinical lung transplantation. Furthermore, to utilize the EVLP technique in research settings thus allowing the evaluation of inflammatory molecules (biomarkers) that would benefit a successful pre-conditioning and increase knowledge of the lungs inflammatory response before transplantation.
Human donor lungs that do not meet the standard clinical criteria for donor lung utilization but fit into the study inclusion criteria will be retrieved from the donor using current donor lung retrieval techniques. These lungs will be brought to the study transplant centre to be perfused in our system by the transplant team. Perfusion of these lungs will be performed using evaluation solution with addition of red blood cells cross matched with the recipient, heparin and antibiotics. Those lungs that after perfusion in our system meet the normal transplantation criteria will be considered for transplantation. Lungs will be excluded for transplantation if the organs don't meet the normal transplantation criteria. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
| Completed |
NCT03299504 -
Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
|
||
| Completed |
NCT00755781 -
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
|
Phase 3 | |
| Recruiting |
NCT05547698 -
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
|
N/A | |
| Terminated |
NCT03207399 -
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
|
Phase 4 | |
| Completed |
NCT03300882 -
PREDICT Cytomegalovirus (CMV)
|
||
| Recruiting |
NCT05101460 -
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
|
||
| Completed |
NCT03150095 -
Health Coaching to Improve Self-Management in Thoracic Transplant Candidates
|
N/A | |
| Completed |
NCT04420195 -
Envarsus XR in Lung Transplant
|
Phase 2 | |
| Not yet recruiting |
NCT06066229 -
Identification of Patient Important Outcomes in Lung Transplantation
|
||
| Recruiting |
NCT04601818 -
Planned Semi-Elective Lung Tx Study
|
N/A | |
| Recruiting |
NCT03072589 -
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
|
Phase 1 | |
| Completed |
NCT01963780 -
International EXPAND Lung Pivotal Trial
|
N/A | |
| Recruiting |
NCT05671887 -
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
|
||
| Completed |
NCT03987113 -
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
|
||
| Recruiting |
NCT02748798 -
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
|
Early Phase 1 | |
| Completed |
NCT03167528 -
Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients
|
N/A | |
| Active, not recruiting |
NCT04244734 -
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
|
N/A | |
| Active, not recruiting |
NCT01365429 -
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
|
N/A | |
| Recruiting |
NCT05055739 -
Comparative Study Between Sternal Closure With Sternalock® Blue Versus Steel Wire Submitted To Bilateral Anterior Transsternal Thoracotomy (Clamshell) For Bilateral Lung Transplant
|
N/A |